FindTrial
Sign In

A Study On Drugs Used In Eczema Patients In a Tertiary Care Hospital

Study On Pharmacological Management In Eczema Patients In Dermatology Department Of a Tertiary Care Teaching Hospital

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2020/12/029854
Enrollment
86
Registered
2020-12-16
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L209- Atopic dermatitis, unspecified

Interventions

None listed

Sponsors

NIL
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All patients diagnosed with eczema aged above 18 years. Either gender. Minimum of 2 drugs per prescription.

Exclusion criteria

Exclusion criteria: Patients not willing to participate in the study. Incomplete information record. Pregnant women and lactating mothers.

Design outcomes

Primary

MeasureTime frame
To study the prescribing patterns of various class of drugs in eczema patients. To study the price variability of different brands of eczema drugs prescribed in the hospital.Timepoint: Single Point—

Secondary

MeasureTime frame
Helps in understanding prescription practices in eczema. Helps in directing future studies and also in developing local policies for appropriate use of drugs in eczema treatment.Timepoint: Single points.—

Countries

India

Contacts

Public ContactDr Shricharith Shetty

Department of Pharmacy Practice, NGSM Institute of Pharmaceutical Sciences, Derlakatte, Mangalore

bharathraj@nitte.edu.in9035948490

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026